Table 2.
Outcomes of critical COVID-19 patients on admission.
| Outcomes | Corticosteroid treatment (n = 68) | Non-corticosteroid treatment (n = 28) | P-value |
|---|---|---|---|
| ARDS | 43 (63%) | 10 (36%) | 0.022 |
| Mechanical ventilation | 36 (53%) | 10 (36%) | 0.143 |
| ICU admission | 45 (66%) | 21 (75%) | 0.397 |
| Case fatality | 46 (68%) | 6 (21%) | 0.001 |
| Exacerbation of pulmonary fibrosis | 38 (56%) | 6 (21%) | 0.005 |
| SOFA | 10.50 (5.25–13.00) | 5.00 (4.00–7.00) | 0.006 |
| Length of hospital stay (survival), days | 24.0 (18.3–38.8) | 17.0 (13.8–25.3) | 0.041 |
| Length of virus clearance time (survival), days | 21.0 (16.8–26.3) | 13.5 (12.0–16.0) | 0.004 |
Data are median (IQR) or n (%). P-values comparing corticosteroid treatment and non-corticosteroid treatment are from Mann-Whitney U test, Chi-Square test, or Fisher's exact test, as appropriate, and adjusted for multiple comparisons by FDR method. ARDS, acute respiratory distress syndrome; ICU, intensive care unit; SOFA, sequential organ failure assessment. The bold P-values indicate P < 0.05.